Details for New Drug Application (NDA): 207746
✉ Email this page to a colleague
The generic ingredient in DOFETILIDE is dofetilide. There are thirteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the dofetilide profile page.
Summary for 207746
Tradename: | DOFETILIDE |
Applicant: | Sigmapharm Labs Llc |
Ingredient: | dofetilide |
Patents: | 0 |
Suppliers and Packaging for NDA: 207746
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOFETILIDE | dofetilide | CAPSULE;ORAL | 207746 | ANDA | Sigmapharm Laboratories, LLC | 42794-044 | 42794-044-10 | 60 CAPSULE in 1 BOTTLE, PLASTIC (42794-044-10) |
DOFETILIDE | dofetilide | CAPSULE;ORAL | 207746 | ANDA | Sigmapharm Laboratories, LLC | 42794-045 | 42794-045-10 | 60 CAPSULE in 1 BOTTLE, PLASTIC (42794-045-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.125MG | ||||
Approval Date: | Mar 26, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.25MG | ||||
Approval Date: | Mar 26, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.5MG | ||||
Approval Date: | Mar 26, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription